Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
1-15 of 234
Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Project Oncology®Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Shelina Ramnarine, PhD
Mohamed Abdelbaki, MD
3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Project Oncology®3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Alexandria May, PharmD, BCPS
Daniel Landi, MD
Rethinking Migraine Prevention: Where CGRP-Targeting Therapies Fit
NeuroFrontiersRethinking Migraine Prevention: Where CGRP-Targeting Therapies Fit
Alexandria May, PharmD, BCPS
Nina Riggins, MD
Treating ADHD in the Presence of Comorbidities
NeuroFrontiersTreating ADHD in the Presence of Comorbidities
Roberto Olivardia, PhD
James Swanson, PhD
Roberto Olivardia, PhD
- advertisement
Untangling ADHD and Co-Occurring Conditions
NeuroFrontiersUntangling ADHD and Co-Occurring Conditions
Roberto Olivardia, PhD
Long-Term ADHD Treatment: Examining Stimulant Tolerance
NeuroFrontiersLong-Term ADHD Treatment: Examining Stimulant Tolerance
James Swanson, PhD
Supporting Students with ADHD and Learning Differences
NeuroFrontiersSupporting Students with ADHD and Learning Differences
Roberto Olivardia, PhD
Multidisciplinary Coordination in TK2d Diagnosis and Management
NeuroFrontiersMultidisciplinary Coordination in TK2d Diagnosis and Management
Charles Turck, PharmD, BCPS, BCCCP
Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Oscar H. (Hank) Mayer, MD
Improving Migraine Diagnosis in Vulnerable Populations
NeuroFrontiersImproving Migraine Diagnosis in Vulnerable Populations
Juliana VanderPluym, MD
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
NeuroFrontiersUnderstanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
Juliana VanderPluym, MD
- advertisement
Shradha Kakde, MBBS
Rethinking Vestibular Migraine in Clinical Practice
NeuroFrontiersRethinking Vestibular Migraine in Clinical Practice
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
NeuroFrontiersVagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
